GlassScriptPhysician profile
Sharon F Pushkin
NPI 1245421486
$2,760.66
in general payments reported to CMS, 2019-2025
29 companies · $96.56 in 2025
The $96.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2020: $299 · 2021: $686 · 2022: $435 · 2023: $235 · 2024: $160 · 2025: $96.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $760.82 | 2019-2023 | |
| Therapeuticsmd, INC. | $260.56 | 2019-2022 | |
| Aspira Women'S Health INC | $172.64 | 2021-2024 | Ova1 |
| Evofem Biosciences, INC. | $172.59 | 2021-2025 | Solosec, Phexx, Phexxi |
| Amgen INC. | $151.76 | 2019 | |
| Agile Therapeutics, INC. | $125.21 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $83.97 | 2021-2025 | |
| Lupin INC. | $82.06 | 2019-2021 | |
| Hologic Sales and Service, LLC | $81.63 | 2019-2023 | Myosure Tissue Removal Device, Aptima |
| Exeltis, USA INC. | $81.26 | 2021-2025 | Slynd |
| Allergan, INC. | $78.97 | 2019-2020 | |
| Valeritas, INC. | $71.95 | 2019 | |
| Myovant Sciences INC. | $65.40 | 2022 | |
| Novo Nordisk INC | $63.99 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $59.76 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $53.29 | 2023 | Givlaari |
| Davol INC. | $50.21 | 2022 | |
| Coopersurgical, INC. | $48.22 | 2020-2022 | |
| Mannkind Corporation | $41.83 | 2019 | |
| Exact Sciences Corporation | $39.74 | 2024 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $39.14 | 2023 | Bd Onclarity |
| Merck Sharp & Dohme LLC | $36.12 | 2019 | |
| Scynexis, INC. | $26.17 | 2022 | |
| Lilly USA, LLC | $26.07 | 2022 | |
| Abbott Laboratories | $23.79 | 2020 | |
| Minerva Surgical, INC | $20.03 | 2021 | |
| Mylan Pharmaceuticals INC. | $16.38 | 2021 | |
| Avion Pharmaceuticals | $14.62 | 2021 | |
| Dysis Medical, INC. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Pushkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.